Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trialTools Forrester, Doug L. and Knox, Alan J. and Smyth, Alan R. and Barr, Helen L. and Simms, Rebecca and Pacey, Sarah J. and Pavord, Ian D. and Honeybourne, David and Dewar, Jane and Clayton, Andy and Fogarty, Andrew W. (2015) Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial. Pediatric Pulmonology, 51 (3). pp. 253-257. ISSN 1099-0496 Full text not available from this repository.AbstractRationale: Pulmonary infection and malnutrition in cystic fibrosis are associated with decreased survival. Glutamine has a possible anti-microbial effect, with a specific impact against Pseudomonas aeruginosa. We aimed to test the hypothesis that oral glutamine supplementation (21 g/day) for 8 weeks in adults with cystic fibrosis would decrease pulmonary inflammation and improve clinical status.
Actions (Archive Staff Only)
|